M&A WATCH- Ibnsina Pharma is looking potential investments in unnamed pharma manufacturing companies through a newly-established special purpose vehicle (SPV), according to an EGX disclosure (pdf). The company is studying “a number” of potential investments and is closing in on signing non-binding offers for the purchase of minority stakes.
More from Enterprise
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
Why EGX stocks are going under the IPO wave
Fund managers are releasing liquidity for ongoing and future IPOs,…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…